Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

NCT02058563 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

996

Enrollment

INDUSTRY

Sponsor class

Conditions

Rubella
Mumps
Measles

Interventions

BIOLOGICAL: Priorix®
BIOLOGICAL: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine

Sponsor

GlaxoSmithKline

Collaborators

[object Object]